title: Nesfatin-1 could be a strong candidate obesity or diabetes medication, if blood pressure elevation can be controlled.
authors.affiliation: Human Neurotransmitters Laboratory and Nucleus Network Ltd, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
authors.forename: Kazuko
authors.initials: K
authors.lastname: Masuo
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002135:Calcium-Binding Proteins / Q000494:pharmacology*; D004268:DNA-Binding Proteins / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D000080866:Nucleobindins
chemical_list: D002135:Calcium-Binding Proteins; D004268:DNA-Binding Proteins; C000630650:NUCB2 protein, human; D009419:Nerve Tissue Proteins; D000080866:Nucleobindins